INTRODUCTION:

Adipose tissue exists in two primary forms: white adipose tissue (WAT), which stores energy, and brown adipose tissue (BAT), which expends energy through thermogenesis. WAT serves as the body’s principal energy storage site and plays a role in cushioning and insulating vital organs. Mature adipocytes in WAT exhibit a gene expression profile that supports triacylglycerol synthesis, glucose uptake, lipogenesis, and lipolysis, enabling the tissue to store excess energy when intake exceeds expenditure, and to mobilize lipids when energy is lacking¹. Fat is stored in the body within two types of adipose tissue: white adipose tissue (WAT) and brown adipose tissue (BAT). Conversely, BAT specializes in oxidizing fatty acids to produce heat², a function driven by the presence of uncoupling protein-1 (UCP-1) in its mitochondria, which disrupts ATP synthesis to generate thermal energy³. Together, the distinct roles of WAT and BAT support systemic energy balance.

Historically considered metabolically inert, WAT is now known to be highly dynamic, actively synthesizing and releasing lipid and protein factors involved in regulating numerous physiological processes. Although it was recognized in the 1980s that WAT secretes steroid hormones⁴, it wasn’t until leptin, which is a satiety hormone primarily secreted by WAT, was discovered in 1994⁵ that the adipose tissue was acknowledged as an endocrine organ. Since then, many other autocrine, paracrine, and endocrine factors have been identified as WAT-derived.

Among WAT secretions, fatty acids are the most quantitatively significant and are released during energy-deficient states such as fasting². Additional lipid molecules include prostanoids, synthesized locally; cholesterol and retinol, stored and later released; and steroid hormones (like sex steroids and glucocorticoids), which undergo activation or deactivation within the tissue and play autocrine and paracrine roles^6,7. Beyond lipid mediators, WAT produces over 50 protein factors termed adipokines. Technically, the term "adipokine" refers to proteins specifically secreted by adipocytes⁸, but it is commonly used to describe proteins secreted by the entire WAT, many of which are produced by other resident cells like infiltrated macrophages. These adipokines exhibit diverse chemical structures and physiological effects^9,10. Adipose tissue exhibits site-specific metabolic activity, and the interplay of adipocytes with preadipocytes, macrophages, lymphocytes, and endothelial cells contributes to metabolic regulation. In pathological conditions like obesity or metabolic syndrome, adipocyte hypertrophy, increased immune infiltration, and altered adipokine secretion become prominent.

Liposuction and abdominoplasty are popular surgical interventions to remove subcutaneous fat and improve body contour. However, the body’s response to localized fat loss may include compensatory adipocyte hypertrophy in non-treated areas. Emerging evidence points to fat redistribution and metabolic signaling changes as drivers of this phenomenon. This study investigates both anthropometric (circumference changes) data and histological (adipocyte size) and histological tissues changes to evaluate adipose tissue remodeling postoperatively. Liposuction and abdominoplasty are popular procedures aimed at improving body aesthetics by removing localized subcutaneous fat deposits¹¹. While the cosmetic benefits are immediate, there is growing concern about potential compensatory fat accumulation in regions not surgically treated¹². Reports indicate that some patients experience increased fat deposition in areas such as the arms, thighs, and buttocks within months of the procedure¹³.

The physiological mechanisms behind this phenomenon remain incompletely understood. While some studies suggest systemic lipogenic signaling pathways may be activated post-liposuction¹⁴, others propose behavioral compensation, such as decreased physical activity post-op, as contributing factors¹⁵. Nonetheless, histological analysis of adipose tissues provides a powerful tool to detect cellular changes, particularly in the size and structure of adipocytes.

Numerous adipokines have been identified, each playing critical regulatory roles across various physiological processes¹⁵. Table 1 highlights several adipokines along with their primary functions. It’s important to note that this endocrine activity is not exclusive to white adipose tissue (WAT), as many of these signaling molecules are also produced by brown adipose tissue (BAT)⁸.

Table 1: Adipokines are secreted by white adipose tissue and have a physiological function.

Adipokine	Function
Leptin	Intake control, fat deposition, and inflammation
Neuropeptide Y (NPY)	Preadipocyte proliferation
Adiponectin	Insulin sensitivity, inflammation
Resistin	Insulin sensitivity, inflammation
Visfatin	Insulin sensitivity, inflammation
Omentin	Insulin sensitivity
Vaspin	Insulin sensitivity
Apelin	Vascular homeostasis (vasodilation), insulin sensitivity?
Adipsin	Inflammation
Cholesterol ester transfer protein (CETP)	Lipid metabolism
Lipoprotein lipase (LPL)	Lipid metabolism
Hormone-sensitive lipase (HSL)	Lipid metabolism
Apolipoprotein E (ApoE)	Lipid metabolism
Retinol binding protein-4 (RBP-4)	Lipid metabolism
Angiotensinogen	Vascular homeostasis
Angiotensin II	Vascular homeostasis
Angiotensin-converting enzyme (ACE)	Vascular homeostasis
Plasminogen activator inhibitor (PAI-1)	Vascular homeostasis
Interleukins (IL-1β, IL-4, IL-6, IL-7, IL-8, IL-10, IL-12, IL-18)	Inflammation, IL-1β is also involved in energy metabolism, insulin sensitivity, and intake control
C-reactive protein (CRP)	Inflammation
Tumor necrosis factor alpha (TNF-α)	Inflammation, insulin sensitivity
Monocyte chemoattractant protein-1 (MCP-1)	Macrophage incorporate into tissue
Intercellular adhesion molecule-1 (ICAM-1)	Macrophage activation
Vascular endothelial growth factor (VEGF)	Angiogenesis
Transforming growth factor beta (TGFβ)	Cell migration and adhesion, cell growth, and differentiation
Insulin-like growth factor type i (IGF-I)	Lipid metabolism, insulin sensitivity
Nerve growth factor (NGF)	Tissue growth and differentiation
Fibroblast growth factor (FGF)	Proliferation and differentiation, angiogenesis
Prostaglandin E2	Vascular homeostasis, inflammation
Prostaglandin I2	Vascular homeostasis, inflammation

Some research suggests that liposuction may lead to compensatory fat growth in non-treated areas, and adipokines might play a role in this process. However, this is not fully understood or guaranteed, and it's likely multifactorial¹⁶.

Adipokines are signaling proteins (like leptin, adiponectin, resistin, TNF-alpha) secreted by fat cells (adipocytes). They help regulate appetite and energy balance (e.g., leptin), Inflammation, Insulin sensitivity, Fat storage, and metabolism¹⁷.

After liposuction, which removes fat cells locally (they're physically suctioned out), the body still "remembers" its former fat stores due to genetic, hormonal, and homeostatic mechanisms. The total body fat "set point" may be defended by the body, leading to fat regain elsewhere (usually visceral fat or in the upper body, like the arms, shoulders, or trunk). It was found that after liposuction, fat can return within a year and be redistributed to other areas. Visceral fat increase was sometimes noted, which is the deeper, more metabolically active (and risky) type of fat. Adipokines like leptin and adiponectin may adjust in response to the new fat distribution, signaling the body to restore balance.⁸ This study aims to assess histological changes in adipocytes, specifically the size of intracellular fat droplets in untreated regions following abdominal fat removal procedures, thereby contributing to the growing body of evidence surrounding fat redistribution.

MATERIALS AND METHODS:

Patient Selection:

Twenty female patients (ages 25–45; BMI 22–28) undergoing elective abdominal liposuction or abdominoplasty in October 6 Hospital Giza-Egypt. were enrolled. Patients with known metabolic disorders, major recent weight fluctuations, or previous surgeries in target measurement areas were excluded. These patients come to clinics to remove fats from other areas Gluteal regions, arms, thighs after being unsatisfied from previous abdominoplasty results due to abnormal deposition of adipose tissue in different body areas.

Follow up of cases after the 1ry surgery of abdominoplasty or liposuction and among them selected 20 female patients undergo 2nd surgical operations to remove adipose tissues from abnormal deposition of fat in different body areas, usual changes postoperatively are summarized in table 2.

This study was conducted in accordance with the ethical standards set forth in the Declaration of Helsinki and its subsequent amendments. All procedures involving human participants were approved by the Institutional Review Board (IRB) or Ethics Committee of Faculty of Medicine, October 6 University Hospital, Egypt, and informed consent was obtained from all individual participants included in the study. Participants were informed of the study's purpose, procedures, potential risks, and their right to withdraw at any time without consequence.

Table 2: Postoperative changes following liposuction or abdominoplasty.

Time After Surgery	What Happens	Measurement Change
Immediately (0–7 days)	Swelling and bruising begin; compression garments are worn	No visible reduction yet (may even look swollen or larger)
1–3 weeks	Swelling starts to go down gradually	Small reduction as body may feel firmer but not much visible change
1–2 months	Most swelling subsides	Noticeable reduction in circumference (somewhere around 50–70% of final result)
3–6 months	Skin retracts and body fully heals	Final, stable measurements — full reduction is visible
6+ months	Results are fully set; scars continue to fade	Circumference stays stable if weight is maintained, samples were taken from other 20 female patients who were unsatisfied due to abnormal deposition of adipose tissues and came for 2ry liposuction from other areas of their bodies, from whom samples are taken for histological examination.

Anthropometric measurements and surgical procedure for liposuction from different body parts, and sample collection.

Certified plastic surgeons performed procedures under general anesthesia using standardized liposuction or abdominoplasty protocols with patients' consent.

Anthropometric Measurements:

The circumferences of the waist, hips, thighs, upper arms, chest, abdomen, and lower back were measured pre- and postoperatively using standard techniques. Additional parameters like the waist-to-hip ratio and BMI were recorded.

Table 3: Anthropometric measurements to detect 1ry liposuction or abdominoplasty postoperative changes.

Parameter	Measurement Method	Healthy/Ideal Range (for women 60–98kg)
Waist Circumference	At the narrowest part of the waist	65 – 85cm
Hip Circumference (Gluteal region)	At the widest part of the buttocks	90 – 110cm
Shoulder Width	Distance between outermost points of shoulders	38 – 45cm
Chest/Bust Circumference	At fullest part of the bust	85 – 105cm

Histological samples collection and analysis:

Adipose biopsies were taken from the gluteal region, lateral thighs, and upper arms preoperatively and six months upwards postoperatively for those who came for 2ry liposuction from other body parts areas. Each biopsy measured ~0.5 cm³.

Tissue samples were fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned at 5 µm, and stained with hematoxylin and eosin (H&E) for microscopic analysis¹⁸. Digital imaging was conducted under 40x magnification, and lipid droplet diameters were measured using ImageJ software. Fixed tissues were embedded in paraffin, sectioned at 5 µm, and stained using:

1. Hematoxylin and Eosin (H&E) – for adipocyte morphology, inflammation, and immune cell infiltration.

2. Sudan III: frozen sections, non-paraffinized-embedded, because lipids dissolved during typical histological preparation.to assess intracellular lipid content and adipocyte hypertrophy.

3. Masson’s Trichrome – to evaluate fibrotic tissue remodeling post-surgery.

Lipid droplet diameters were analyzed using ImageJ software under 40x magnification. Paired t-tests compared pre- and postoperative measurements. A p-value < 0.05 was considered statistically significant.

Significant increases in lipid droplet diameter were observed postoperatively across multiple regions. In the gluteal region, the diameter increased from 42.6±5.2µm to 57.3±4.6µm (p=0.002), while in the thighs it rose from 39.1±4.9µm to 54.2±5.1µm (p = 0.001), and in the arms, from 35.4±3.8µm to 48.7±4.5µm (p=0.004). These findings indicate a statistically significant enlargement in lipid droplet size. A rare increase in adipocyte number was also detected, confirming that the observed adipose tissue expansion was primarily due to hypertrophy rather than hyperplasia.

Histological analysis further supports these findings. Hematoxylin and Eosin (H&E) staining, as shown in Figure 1(A, B, C), reveals that hematoxylin stains nuclei blue/purple (basophilic), while eosin stains the cytoplasm and extracellular matrix pink/red (acidophilic). Masson's Trichrome staining, illustrated in Figure 1(D, E, F), highlights collagen fibers in blue or green, muscle and cytoplasm in red, and nuclei in black or dark purple. Sudan III staining, demonstrated in Figure 1(G, H, I), shows neutral lipids such as triglycerides and cholesteryl esters in orange-red, emphasizing the presence of lipid accumulation within the tissues.

Table 4: Significant increases were observed in untreated regions, while abdominal measurements decreased.

Body Area	Pre-op (inches)	Post-op (inches)	Change (inches)
Waist	31.0	36.5	+5.5
Hips (Gluteal region)	37.8	42.0	+4.2
Thigh	21.5	25.0	+3.5
Upper Arms	12.2	14.5	+2.3
Abdomen	38.0	32.5	-5.5
Lower Back	30.0	34.0	+4.0
Chest (Men)	40.0	44.0	+4.0
Neck	12.0	12.5	+0.5

DISCUSSION:

Histological and anthropometric evidence confirm a compensatory hypertrophy response in non-treated adipose regions following abdominal liposuction. Enlarged adipocytes in the thighs, gluteal region, and arms indicate lipid accumulation driven by systemic compensatory mechanisms.

Liposuction can trigger several physiological responses in the body due to the sudden removal of fat cells. One of the key mechanisms is homeostatic compensation, where the body attempts to return to its original "set point" weight or fat mass. This is closely related to adipokine feedback; as the number of fat cells decreases, the secretion of leptin—a hormone that helps regulate hunger and metabolism—also drops. The brain may interpret this reduction as a signal of fat loss, potentially triggering increased hunger or encouraging fat storage in other areas. Another factor is stem cell redistribution, where pre-adipocytes, or immature fat cells, may become more active in untreated regions, contributing to fat accumulation elsewhere after surgery. As a result, liposuction may sometimes lead to fat regain in parts of the body that weren't targeted. Adipokines play a significant role in how the body responds to this sudden loss of fat cells. However, these outcomes are not guaranteed and can often be minimized by maintaining a healthy lifestyle post-operation.

The biological rationale behind fat redistribution post-liposuction is multifactorial. Homeostatic regulation plays a key role, as the body attempts to restore fat balance through hormonal feedback mechanisms—most notably, the downregulation of leptin following fat removal. Adipokine signaling is also disrupted; altered secretion levels of leptin, adiponectin, and TNF-α may influence how and where the body stores fat. In addition, liposuction may trigger stem cell recruitment, activating preadipocytes in untreated areas, which in turn enhances lipid uptake and storage. Meanwhile, fibrotic changes in the treated areas can mechanically restrict adipocyte expansion, forcing the body to redirect fat storage to other, untreated regions.

Histological staining techniques offer key insights into these processes. Hematoxylin and Eosin (H&E) staining commonly reveals enlarged adipocytes, indicating hypertrophy, or small newly formed adipocytes, signaling hyperplasia. Crown-like structures (CLSs)—clusters of macrophages around dead or dying adipocytes—suggest ongoing inflammation or adipocyte turnover, while increased vascularity and cellularity can reflect active tissue remodeling. The presence of CLSs often correlates with low-grade inflammation, which can promote metabolic dysfunction and further fat accumulation.

Masson’s Trichrome stain is particularly useful for visualizing fibrosis. In post-liposuction samples, it may reveal mild to moderate fibrosis between adipocytes or along connective tissue septa. Thickened collagen fibers seen in these stains suggest tissue repair or scarring and confirm a remodeling response. Such fibrosis can contribute to mechanical restriction of adipocyte expansion in the treated areas, further encouraging fat deposition elsewhere in the body.

Sudan III or Oil Red O staining highlights lipid content. These stains often show uniform coloration of large fat droplets within hypertrophied adipocytes. In areas undergoing compensatory growth, larger and more numerous fat droplets reflect active lipid accumulation. Occasionally, smaller stained droplets appear, indicating lipid storage by preadipocytes—a sign of hyperplasia. This confirms active lipid storage, especially in untreated areas, and visually supports the concept of compensatory hypertrophy in distant fat depots.

These findings mirror previous imaging-based and biochemical studies and underscore the need for comprehensive postoperative management strategies, including physical activity and diet optimization. Particularly in male patients, education around postoperative body proportion changes is essential.

CONCLUSION:

This study demonstrates that liposuction or abdominoplasty may trigger compensatory adipocyte hypertrophy in non-treated regions, affecting body contour outcomes. This study also provides histological confirmation that untreated adipose regions may undergo compensatory enlargement of existing adipocytes following abdominal fat reduction surgery. These findings are consistent with prior imaging-based studies suggesting fat redistribution post-liposuction²⁰.

Physiologically, removal of subcutaneous adipose tissue may disrupt energy storage equilibrium, prompting lipid accumulation in other depots²¹. Additionally, systemic changes in adipokines, insulin sensitivity, and lipogenic enzyme expression have been implicated²². Importantly, patients should be informed about this possibility during preoperative consultations, and lifestyle interventions should be emphasized as a component of postoperative care.

Furthermore, the absence of new adipocyte formation supports the concept that mature adipocytes remain plastic and capable of significant hypertrophy in response to metabolic demands^23-25.

Histological data confirm the enlargement of existing adipocytes without evidence of hyperplasia. These findings highlight the importance of preoperative counseling and holistic postoperative care to maintain aesthetic results and manage expectations^26-29.

We can conclude that after liposuction, the remaining or distant fat depots may undergo structural and functional changes. Histological analysis helps reveal how and why fat might hypertrophy (grow in size) elsewhere³⁰.

The most likely cause of post-liposuction hypertrophy appears to be a combination of homeostatic compensatory mechanisms and adipokine dysregulation. The human body tightly regulates fat mass through complex hormonal and neuroendocrine feedback loops, with hormones such as leptin playing a central role. While liposuction effectively removes fat cells from targeted areas, it does not address the underlying regulatory systems that govern fat storage and energy balance³¹. As a result, the body may interpret the sudden reduction in fat as a deficit that needs to be corrected. This perceived imbalance leads to decreased circulating leptin levels, since leptin is secreted by adipocytes³², which the brain interprets as a signal of energy insufficiency, triggering increased hunger or energy conservation mechanisms. Concurrently, there is often a compensatory increase in adipogenesis within untreated regions, either through forming new adipocytes or enlarging existing ones^33,34. Additionally, insulin sensitivity tends to increase in the remaining fat depots, further promoting lipid uptake and storage in these areas, contributing to the hypertrophy observed after liposuction.

REFERENCE:

1. Xu S, Lu F, Gao J, Yuan Y. Inflammation-mediated metabolic regulation in adipose tissue. Obes Rev. 2024 Jun; 25(6): e13724. doi:10.1111/obr.13724.

2. Reilly S, Aksu A, Zerbel Z, Fatty acids promote uncoupled respiration via the ATP/ADP carrier in white adipocytes. Res Sq. 2024 Sep 25; rs.3.rs-5094089. doi: 10.21203/rs.3.rs-5094089/v1.

3. Liu X, Zhang Z, Song Y, et al. An update on brown adipose tissue and obesity intervention: Function, regulation and therapeutic implications. Front Endocrinol (Lausanne). 2023; 13: 1065263. doi:10.3389/fendo.2022.1065263.

4. Gómez-Ambrosi J. Adipose tissue inflammation. Cells. 2023;12(11):1484. doi:10.3390/cells12111484.

5. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32. doi:10.1038/372425a0.

6. Trayhurn P. Endocrine and signaling role of adipose tissue: new perspectives on fat. Acta Physiol Scand. 2005; 184(4): 285–93. doi:10.1111/j.1365-201X.2005.01468.x.

7. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001; 294(5549): 2166–70. doi:10.1126/science.1066285.

8. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92(3): 347–55.

9. Vázquez-Vela ME, Torres N, Tovar AR. White adipose tissue as an endocrine organ and its role in obesity. Arch Med Res. 2008; 39(8): 715–28. doi:10.1016/j.arcmed.2008.09.005.

10. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005; 19(4): 547–66. doi:10.1016/j.beem.2005.07.009.

11. Rohrich RJ, Beran SJ. Discussion: Suction-assisted lipectomy: principles and techniques. Plast Reconstr Surg. 1998; 101(2): 630–2.

12. Hernandez TL, et al. Fat redistribution following suction lipectomy: defense of body fat and patterns of restoration. Obesity (Silver Spring). 2011; 19(7): 1388–95.

13. Tashiro K, et al. Body fat redistribution after suction lipectomy and its prevention with exercise. Aesthetic Plast Surg. 2014; 38(5): 1023–30.

14. Choe R, et al. Metabolic and endocrine changes after liposuction: a review. J Cosmet Dermatol. 2018; 17(2): 191–6.

15. Fischer S, et al. Mental and physical well-being after liposuction: a follow-up study. Aesthetic Plast Surg. 2010; 34(5): 721–6.

16. American Society of Plastic Surgeons. Guidelines for patient selection and preoperative assessment. 2022.

17. Illouz YG. Body contouring by lipolysis: a 5-year experience with over 3000 cases. Plast Reconstr Surg. 1983; 72(5): 591–7.

18. Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. 7th ed. Elsevier; 2013.

19. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011; 121(6): 2094–101.

20. Gonzalez-Campoy JM. The role of liposuction in fat distribution and obesity treatment. Obes Res Clin Pract. 2010; 4(2): e79–87.

21. Medina-Gomez G. Mitochondria and endocrine function of adipose tissue. Best Pract Res Clin Endocrinol Metab. 2012; 26(6): 791–804.

22. Havel PJ. Control of energy homeostasis and lipoprotein metabolism by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002; 13(1): 51–9.

23. Spalding KL, et al. Dynamics of fat cell turnover in humans. Nature. 2008; 453(7196): 783–7.

24. Viktor P, Kaur L, Jai Pillai HP, Khalaf OM, Mudhafar M, Hasan H, Devi J, Alaban AG, Calvin R. Wei, Jamali M, Mahedi RA, Syrmos N, Sejuti SR. Exposures to Poisoning to Forensic Investigations and Public Health Views - A Toxicology Tapestry. Research Journal of Pharmacy and Technology. 2025; 18(1): 402-8. doi: 10.52711/0974-360X.2025.00062

25. R. Bennet, A. Arun, Mark Keith Faraday. A Study on the Nutritive Analysis of Almond Intake for Optimal Muscle Hypertrophy. Research J. Pharm. and Tech. 2018; 11(10): 4539-4542. doi: 10.5958/0974-360X.2018.00830.2

26. Nabilah N, García DG, Kondaveeti SB, Batra H.S., Viktor P, Jamali MC, Wei CR, Bhuiyan JR, Mudhafar M, Khalaf OM, Syrmos N, Roy S, Matyakubovich AK, Afrin S, Mahedi MRA. Examining the Interplay of Psychological Factors in Chronic Skin Disease: A Review on Depression, Anxiety, and Stress. Research Journal of Pharmacy and Technology.2024; 17(4): Research Journal of Pharmacy and Technology. 2024; 17(4): 1902-8. doi: 10.52711/0974-360X.2024.00302

27. Babu KT, Nivetha R, Das R, Saraswathy R. Use of Doppler Echocardiography as a Prognostic Marker in Evaluating Hypertensive Patients with and without left Ventricular Hypertrophy – A Hospital Based Study in Vellore. Research J. Pharm. and Tech. 2018; 11(9): 3983-3989. doi: 10.5958/0974-360X.2018.00732.1

28. Afrin S, Jai Pillai HP, Emmanuel E S, Viktor P, Hafiz MA, Al-Aouadi RFA, Mahedi RA, Mudhafar M, Batra H.S., Kondaveeti SB, Syrmos N, Jamali MC, Al-Azzawi AKJ, Wei CR, Elahi MME. A Systematic Review of Bioinformatics' Influence on Drug Developments. Research Journal Pharmacy and Technology. 2024; 17(12): 6158-4. doi: 10.52711/0974-360X.2024.00934

29. Deepak A, Kumar S. Anthropometric Measurements of External Ear. Research J. Pharm. and Tech. 2016; 9(9): 1379-1381. doi: 10.5958/0974-360X.2016.00264.X

30. Mahedi MRA, Mounich K, Hsu CY, Bhuiyan JR, Jasim IK, Khalaf OM, Darshan J C, Wei CR., Mushfique MB, Syrmos N, Afrin S, Singh P. Cefiderocol (CFDC): A Spy Antibiotic Future Replacement of Carbapenem. Research Journal of Pharmacy and Technology. 2023; 16(11): 5492-6. doi: 10.52711/0974-360X.2023.00888

31. Sourav V, Anupama N, Kumar NA, Kulyadi CP, Sowndarya K. Effect of intermittent fasting and complete fasting on biochemical and histological parameters in high fat high sugar induced rat model of obesity. Research Journal of Pharmacy and Technology. 2022; 15(11): 5094-8. doi: 10.52711/0974-360X.2022.00856

32. Nishad S, Kumar M, Anant SK, Srivastava P, Venugopal R. A Study of Anthropometric and Psychological Discriminating Factors of Hypertension. Research J. Pharm. and Tech. 2019; 12(6): 2995-2998. doi: 10.5958/0974-360X.2019.00506.7

33. Bhattachary K, Kulshrestha R, Barman SS, Bhaduri D. A small cross-sectional assessment of Physiological Health Status in relation to Anthropometric and Cardio-Respiratory Indices among Head-Supported Load Carrying Female Porters of Sikkim, India. Research J. Pharm. and Tech. 2018; 11(5): 1990-1995. doi: 10.5958/0974-360X.2018.00370.0

34. Bala BK, Kaur L, Vargas JAY, Camones CHP, Ansari ARMA, Taloba AI. Lung cancer diagnosis using statistical methods and the Raman spectroscopy model. In: AIP Conference Proceedings. AIP Publishing; 2025. p. 020033.

Received on 20.04.2025 Revised on 14.08.2025

Accepted on 16.10.2025 Published on 20.05.2026

Available online from May 25, 2026

Research J. Pharmacy and Technology. 2026;19(5):2024-2030.

DOI: 10.52711/0974-360X.2026.00290

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.